Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma-Reference-Cited by-同舟云学术

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma

Published:2023-06 Issue: Volume:20 Page:100675
ISSN:2590-0064
Container-title:Materials Today Bio
language:en
Short-container-title:Materials Today Bio

Author:

Xiang Dongquan,Han Xinli,Li Jianxiong,Zhang Jiabing,Xiao Haihua,Li Ting,Zhao Xuelin,Xiong Hejian,Xu Meng,Bi Wenzhi^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biomedical Engineering,Biomaterials,Bioengineering,Biotechnology

Reference56 articles.

1. Novel therapeutic strategies for spinal osteosarcomas;Anwar;Semin. Cancer Biol.,2020

2. Advancing therapy for osteosarcoma;Gill;Nat. Rev. Clin. Oncol.,2021

3. Translational biology of osteosarcoma;Kansara;Nat. Rev. Cancer,2014

4. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway;Viswanathan;Nature,2017

5. Recent progress on activatable nanomedicines for immunometabolic combinational cancer therapy;Zhang;Small Structures,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy;Biomaterials;2025-02

2. cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy;European Polymer Journal;2024-10

3. Targeting metabolic pathways to counter cancer immunotherapy resistance;Trends in Immunology;2024-07

4. Nanoparticle targeting cGAS-STING signaling in disease therapy;Nano Research;2024-06-15

5. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies;Frontiers in Cell and Developmental Biology;2024-06-10